keyword
https://read.qxmd.com/read/38602847/nascent-shifts-in-renal-cellular-metabolism-structure-and-function-due-to-chronic-empagliflozin-in-prediabetic-mice
#21
JOURNAL ARTICLE
Blythe D Shepard, Jennifer Chau, Ryan Kurtz, Avi Z Rosenberg, Pinaki Sarder, Samuel P Border, Brandon Ginley, Olga Rodriguez, Chris Albanese, Grace Knoer, Aarenee Greene, Aline M A De Souza, Suman Ranjit, Moshe Levi, Carolyn M Ecelbarger
Sodium-glucose cotransporter, type 2 inhibitors (SGLT2i) are emerging as the gold standard for treatment of type 2 diabetes (T2D) with renal protective benefits independent of glucose lowering. We took a high-level approach to evaluate the effects of the SGLT2i, empagliflozin (EMPA) on renal metabolism and function in a prediabetic model of metabolic syndrome. Male and female 12-wk-old TallyHo (TH) mice, and their closest genetic lean strain (Swiss-Webster, SW) were treated with a high-milk-fat diet (HMFD) plus/minus EMPA (@0...
April 1, 2024: American Journal of Physiology. Cell Physiology
https://read.qxmd.com/read/38602612/characteristics-of-the-oral-microbiota-in-patients-with-primary-sj%C3%A3-gren-s-syndrome
#22
JOURNAL ARTICLE
Yiwen Xie, Yu Fan, Miaotong Su, Yukai Wang, Guohong Zhang
OBJECTIVE: Primary Sjögren's syndrome (pSS) is an autoimmune disease with unknown etiology that is considered to be related to environmental and genetic factors. The aim of this study was to clarify the oral microflora characteristics of pSS patients and to reveal the connection between oral bacterial composition and dental caries using a high-throughput sequencing technique. METHODS: Thirty-five pSS patients and 20 healthy controls were enrolled in this study...
April 11, 2024: Clinical Rheumatology
https://read.qxmd.com/read/38601207/research-progress-on-the-mechanism-of-tcm-regulating-intestinal-microbiota-in-the-treatment-of-dm-mellitus
#23
REVIEW
Yang Ping, Jianing Liu, Lihong Wang, Hongbin Qiu, Yu Zhang
In recent years, with the improvement of people's living standards, the incidence of DM has increased year by year in China. DM is a common metabolic syndrome characterized by hyperglycemia caused by genetic, environmental and other factors. At the same time, long-term suffering from DM will also have an impact on the heart, blood vessels, eyes, kidneys and nerves, and associated serious diseases. The human body has a large and complex gut microbiota, which has a significant impact on the body's metabolism...
2024: Frontiers in Endocrinology
https://read.qxmd.com/read/38600622/epigenetic-circadian-clocks-and-pcos
#24
JOURNAL ARTICLE
Camille Vatier, Sophie Christin-Maitre
Polycystic ovary syndrome (PCOS) affects 6-20% of reproductive-aged women. It is associated with increased risks of metabolic syndrome, Type 2 diabetes, cardiovascular diseases, mood disorders, endometrial cancer and non-alcoholic fatty liver disease. Although various susceptibility loci have been identified through genetic studies, they account for ∼10% of PCOS heritability. Therefore, the etiology of PCOS remains unclear. This review explores the role of epigenetic changes and modifications in circadian clock genes as potential contributors to PCOS pathogenesis...
April 10, 2024: Human Reproduction
https://read.qxmd.com/read/38599558/brugada-phenocopy-vs-brugada-syndrome-delineating-the-differences-for-optimal-diagnosis-and-management
#25
REVIEW
Galih Januar Adytia, Henry Sutanto
Brugada syndrome (BrS) is a genetic disorder known for its characteristic electrocardiogram (ECG) patterns and increased risk of sudden cardiac death. Brugada phenocopy (BrP) presents similar ECG patterns but is distinguished by its reversible nature when the underlying conditions are resolved. This article delineates the intricacies of BrP, emphasizing its etiology, clinical presentation, diagnosis, treatment, and prognosis. The article categorizes BrP based on various underlying causes, including metabolic disturbances, myocardial infarction, and mechanical compression, among others...
April 8, 2024: Current Problems in Cardiology
https://read.qxmd.com/read/38599513/a-high-seizure-burden-increases-several-prostaglandin-species-in-the-hippocampus-of-a-scn1a-mouse-model-of-dravet-syndrome
#26
JOURNAL ARTICLE
Cilla Zhou, Vaishali Satpute, Ka Lai Yip, Lyndsey L Anderson, Nicole Hawkins, Jennifer Kearney, Jonathon C Arnold
Dravet syndrome is an intractable epilepsy with a high seizure burden that is resistant to current anti-seizure medications. There is evidence that neuroinflammation plays a role in epilepsy and seizures, however few studies have specifically examined neuroinflammation in Dravet syndrome under conditions of a higher seizure burden. Here we used an established genetic mouse model of Dravet syndrome (Scn1a+/- mice), to examine whether a higher seizure burden impacts the number and morphology of microglia in the hippocampus...
April 8, 2024: Prostaglandins & Other Lipid Mediators
https://read.qxmd.com/read/38590945/activity-of-isoflavone-in-managing-polycystic-ovary-syndrome-symptoms-review
#27
REVIEW
Cut Raihanah, Sukrasno Sukrasno, Neng Fisheri Kurniati
Polycystic ovary syndrome (PCOS), a hormonal and metabolic disorder manifested in women of reproductive age, is still being treated using drugs with side effects. As an alternative to these drugs, isoflavone, also identified as phytoestrogen, has anti-PCOS activity. Isoflavone can help relieve PCOS symptoms by lowering the level of testosterone, which causes hyperandrogenism, thereby normalizing the menstrual cycle and restoring normal ovarian morphology. Furthermore, isoflavone influences the improvement of the metabolic profile, which changes because of PCOS, as well as the reduction of inflammatory markers and oxidative stress...
May 2024: Biomedical Reports
https://read.qxmd.com/read/38586466/genetic-profile-of-a-large-spanish-cohort-with-hypercalcemia
#28
JOURNAL ARTICLE
Alejandro García-Castaño, Leire Madariaga, Sara Gómez-Conde, Pedro González, Gema Grau, Itxaso Rica, Gustavo Pérez de Nanclares, Ana Belén De la Hoz, Aníbal Aguayo, Rosa Martínez, Inés Urrutia, Sonia Gaztambide, Luis Castaño
INTRODUCTION: The disorders in the metabolism of calcium can present with manifestations that strongly suggest their diagnosis; however, most of the time, the symptoms with which they are expressed are nonspecific or present only as a laboratory finding, usually hypercalcemia. Because many of these disorders have a genetic etiology, in the present study, we sequenced a selection of 55 genes encoding the principal proteins involved in the regulation of calcium metabolism. METHODS: A cohort of 79 patients with hypercalcemia were analyzed by next-generation sequencing...
2024: Frontiers in Endocrinology
https://read.qxmd.com/read/38585545/severe-early-onset-obesity-and-diabetic-ketoacidosis-due-to-a-novel-homozygous-c-169c-t-p-arg57-variant-in-cep19-gene
#29
JOURNAL ARTICLE
Atilla Cayir, Ayberk Turkyilmaz, Hannah Rabenstein, Fadime Guven, Yuksel Sumeyra Karagoz, Dogus Vuralli, Martin Wabitsch, Huseyin Demirbilek
INTRODUCTION: Early-onset severe obesity is usually the result of an underlying genetic disorder, and several genes have recently been shown to cause syndromic and nonsyndromic forms of obesity. The " centrosomal protein 19 ( CEP19 ) " gene encodes for a centrosomal and ciliary protein. Homozygous variants in the CEP19 gene are extremely rare causes of early-onset severe monogenic obesity. Herein, we present a Turkish family with early-onset severe obesity with variable features. METHODS: Sanger sequencing and whole-exome sequencing were performed to identify the genetic etiology in the family...
March 2024: Molecular Syndromology
https://read.qxmd.com/read/38581234/gene-replacement-therapies-for-inherited-disorders-of-neurotransmission-current-progress-in-succinic-semialdehyde-dehydrogenase-deficiency
#30
JOURNAL ARTICLE
Henry H C Lee, Itay Tokatly Latzer, Mariarita Bertoldi, Guangping Gao, Phillip L Pearl, Mustafa Sahin, Alexander Rotenberg
Neurodevelopment is a highly organized and complex process involving lasting and often irreversible changes in the central nervous system. Inherited disorders of neurotransmission (IDNT) are a group of genetic disorders where neurotransmission is primarily affected, resulting in abnormal brain development from early life, manifest as neurodevelopmental disorders and other chronic conditions. In principle, IDNT (particularly those of monogenic causes) are amenable to gene replacement therapy via precise genetic correction...
April 6, 2024: Journal of Inherited Metabolic Disease
https://read.qxmd.com/read/38581036/consumption-of-dietary-fiber-and-apoa5-genetic-variants-in-metabolic-syndrome-baseline-data-from-the-korean-medicine-daejeon-citizen-cohort-study
#31
JOURNAL ARTICLE
Jimi Kim, Younghwa Baek, Siwoo Lee
BACKGROUND: Consumption of dietary fiber has been suggested as an important aspect of a healthy diet to reduce the risk of metabolic syndrome (MetS), including cardiovascular disease. The role of fiber intake in MetS might differ by individual genetic susceptibility. APOA5 encodes a regulator of plasma triglyceride levels, which impacts the related mechanisms of MetS. This study investigated the association between dietary fiber and the risk of MetS, assessing their associations according to APOA5 genetic variants...
April 5, 2024: Nutrition & Metabolism
https://read.qxmd.com/read/38577740/cystic-fibrosis-foundation-evidence-based-guideline-for-the-management-of-crms-cfspid
#32
JOURNAL ARTICLE
Deanna M Green, Thomas Lahiri, Karen S Raraigh, Fadel Ruiz, Jacquelyn Spano, Nicholas Antos, Lynn Bonitz, Lillian Christon, Myrtha Gregoire-Bottex, Jaime E Hale, Elinor Langfelder-Schwind, Álvaro La Parra Perez, Karen Maguiness, John Massie, Erin McElroy-Barker, Meghan E McGarry, Angelique Mercier, Anne Munck, Kathryn E Oliver, Staci Self, Kathryn Singh, Michael Smiley, Steven Snodgrass, Audrey Tluczek, Pamela Tuley, Paula Lomas, Elise Wong, Sarah E Hempstead, Albert Faro, Clement L Ren
A multidisciplinary committee developed evidence-based guidelines for the management of cystic fibrosis transmembrane conductance regulator-related metabolic syndrome/cystic fibrosis screen-positive, inconclusive diagnosis (CRMS/CFSPID). A total of 24 patient, intervention, comparison, and outcome questions were generated based on surveys sent to people with CRMS/CFSPID and clinicians caring for these individuals, previous recommendations, and expert committee input. Four a priori working groups (genetic testing, monitoring, treatment, and psychosocial/communication issues) were used to provide structure to the committee...
April 5, 2024: Pediatrics
https://read.qxmd.com/read/38577539/update-in-lean-metabolic-dysfunction-associated-steatotic-liver-disease
#33
JOURNAL ARTICLE
Karina Sato-Espinoza, Perapa Chotiprasidhi, Mariella R Huaman, Javier Díaz-Ferrer
BACKGROUND: A new nomenclature consensus has emerged for liver diseases that were previously known as non-alcoholic fatty liver disease (NAFLD) and metabolic dysfunction-associated fatty liver disease (MAFLD). They are now defined as metabolic dysfunction-associated steatotic liver disease (MASLD), which includes cardiometabolic criteria in adults. This condition, extensively studied in obese or overweight patients, constitutes around 30% of the population, with a steady increase worldwide...
March 27, 2024: World Journal of Hepatology
https://read.qxmd.com/read/38576930/alstrom-syndrome-with-classical-findings-a-rare-case-report-of-monogenic-ciliopathy-co-occurrence-in-twins
#34
Sagun Ghimire, Suman Simkhada, Samir Thapa, Kiran Ghising
INTRODUCTION AND IMPORTANCE: Alstrom syndrome is one of the rarest monogenic ciliopathy belonging to autosomal recessive disorder. The pathophysiology of Alstrom syndrome is not well understood but based upon the available medical literature its mechanism can be linked with recessive mutation in Alstrom syndrome 1(ALSM1) gene resulting in various multiple organ involvement and poor prognosis. Moreover the co-occurrence of such syndrome simultaneously in twins in same period of time is considered rare...
April 2024: Annals of Medicine and Surgery
https://read.qxmd.com/read/38574752/is-there-a-safe-alcohol-consumption-limit-for-the-general-population-and-in-patients-with-liver-disease
#35
JOURNAL ARTICLE
Manuel Romero-Gómez, Juan Pablo Arab, Claudia P Oliveira, María Hernández, Marco Arrese, Helena Cortez-Pinto, Ramón Bataller
Excessive alcohol consumption represents an important burden for health systems worldwide and is a major cause of liver- and cancer-related deaths. Alcohol consumption is mostly assessed by self-report that often underestimates the amount of drinking. While alcohol use disorders identification test - version C is the most widely used test for alcohol use screening, in patients with liver disease the use of alcohol biomarker could help an objective assessment. The amount of alcohol that leads to significant liver disease depends on gender, genetic background, and coexistence of comorbidities (i...
April 4, 2024: Seminars in Liver Disease
https://read.qxmd.com/read/38572511/administration-of-adiponectin-receptor-agonist-adiporon-relieves-cancer-cachexia-by-mitigating-inflammation-in-tumour-bearing-mice
#36
JOURNAL ARTICLE
Isabelle S Massart, Axell-Natalie Kouakou, Nathan Pelet, Pascale Lause, Olivier Schakman, Audrey Loumaye, Michel Abou-Samra, Louise Deldicque, Laure B Bindels, Sonia M Brichard, Jean-Paul Thissen
BACKGROUND: Cancer cachexia is a life-threatening, inflammation-driven wasting syndrome that remains untreatable. Adiponectin, the most abundant adipokine, plays an important role in several metabolic processes as well as in inflammation modulation. Our aim was to test whether administration of AdipoRon (AR), a synthetic agonist of the adiponectin receptors, prevents the development of cancer cachexia and its related muscle atrophy. METHODS: The effect of AR on cancer cachexia was investigated in two distinct murine models of colorectal cancer...
April 4, 2024: Journal of Cachexia, Sarcopenia and Muscle
https://read.qxmd.com/read/38571879/a-novel-mitochondrial-dna-variant-in-mt-nd6-m-14430a-c-p-trp82gly-identified-in-a-patient-with-leigh-syndrome-and-complex-i-deficiency
#37
JOURNAL ARTICLE
Surita Meldau, Sally Ackermann, Gillian Riordan, George F van der Watt, Careni Spencer, Sharika Raga, Kashief Khan, Dee M Blackhurst, Francois H van der Westhuizen
Leigh syndrome is a severe progressive mitochondrial disorder mainly affecting children under the age of 5 years. It is caused by pathogenic variants in any one of more than 75 known genes in the nuclear or mitochondrial genomes. A 19-week-old male infant presented with lactic acidosis and encephalopathy following a 2-week history of irritability, neuroregression and poor weight gain. He was hypotonic with pathological reflexes, impaired vision, and nystagmus. Brain MRI showed extensive bilateral symmetrical T2 hyperintense lesions in basal ganglia, thalami, and brainstem...
June 2024: Molecular Genetics and Metabolism Reports
https://read.qxmd.com/read/38567309/exploring-the-bidirectional-relationship-between-metabolic-syndrome-and-thyroid-autoimmunity-a-mendelian-randomization-study
#38
JOURNAL ARTICLE
Kefan Chen, Wei Sun, Liang He, Wenwu Dong, Dalin Zhang, Ting Zhang, Hao Zhang
BACKGROUND: Observational studies have reported a possible association between metabolic syndrome (MetS) and thyroid autoimmunity. Nevertheless, the relationship between thyroid autoimmunity and MetS remains unclear. The objective of this research was to assess the causal impact of MetS on thyroid autoimmunity through the utilization of Mendelian randomization (MR) methodology. METHODS: We performed bidirectional MR to elucidate the causal relationship between MetS and their components and thyroid autoimmunity (positivity of TPOAb)...
2024: Frontiers in Endocrinology
https://read.qxmd.com/read/38566958/case-report-avoiding-intolerance-to-antipsychotics-through-a-personalized-treatment-approach-based-on-pharmacogenetics
#39
Liam Korošec Hudnik, Tanja Blagus, Sara Redenšek Trampuž, Vita Dolžan, Jurij Bon, Milica Pjevac
INTRODUCTION: The standard approach to treatment in psychiatry is known as "treatment as usual" (TAU), in which the same types of treatment are administered to a group of patients. TAU often requires numerous dose adjustments and medication changes due to ineffectiveness and/or the occurrence of adverse drug reactions (ADRs). This process is not only time-consuming but also costly. Antipsychotic medications are commonly used to treat various psychiatric disorders such as schizophrenia and mood disorders...
2024: Frontiers in Psychiatry
https://read.qxmd.com/read/38562431/the-association-between-mitochondrial-trna-glu-variants-and-hearing-loss-a-case-control-study
#40
JOURNAL ARTICLE
Xuejiao Yu, Sheng Li, Qinxian Guo, Jianhang Leng, Yu Ding
PURPOSE: This study aimed to examine the frequencies of mt-tRNAGlu variants in 180 pediatric patients with non-syndromic hearing loss (NSHL) and 100 controls. METHODS: Sanger sequencing was performed to screen for mt-tRNAGlu variants. These mitochondrial DNA (mtDNA) pathogenic mutations were further assessed using phylogenetic conservation and haplogroup analyses. We also traced the origins of the family history of probands carrying potential pathogenic mtDNA mutations...
2024: Pharmacogenomics and Personalized Medicine
keyword
keyword
1638
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.